3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Gynecologic
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
10
Small Cell Lung Carcinoma
4
Esophageal Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Breast Neoplasms
3
Salivary Gland Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Nasopharyngeal Neoplasms
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Fallopian Tube Neoplasms
2
Congenital Abnormalities
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Waldenstrom Macroglobulinemia
1
Tobacco Use Disorder
1
Testicular Neoplasms
1
Teratoma, Testicular
1
Interventions
pembrolizumab
4
spartalizumab
3
Nivolumab
2
tislelizumab
1
obinutuzumab
1
naptumomab estafenatox
1
durvalumab
1
Topotecan
1
Polymerase Chain Reaction
1
Mass Spectrometry
1
In Situ Hybridization, Fluorescence
1
Immunohistochemistry
1
Gemcitabine
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Polymerase Chain Reaction
×
Thoracic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled